CancerNetwork® (@cancernetwrk) 's Twitter Profile
CancerNetwork®

@cancernetwrk

Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.

ID: 22195223

linkhttp://www.cancernetwork.com calendar_today27-02-2009 21:48:14

20,20K Tweet

29,29K Takipçi

625 Takip Edilen

CancerNetwork® (@cancernetwrk) 's Twitter Profile Photo
CancerNetwork®
@cancernetwrk

4 days ago

The European Commission has approved brentuximab vedotin in combination with ECADD chemotherapy as a treatment for adult patients with newly diagnosed stage IIb with risk factors, stage III, and stage IV Hodgkin lymphoma. #lymsm hubs.li/Q03qMt5Z0

The European Commission has approved brentuximab vedotin in combination with ECADD chemotherapy as a treatment for adult patients with newly diagnosed stage IIb with risk factors, stage III, and stage IV Hodgkin lymphoma. #lymsm hubs.li/Q03qMt5Z0